Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Zoledronic acid Fresenius Kabi 4 mg/5 ml concentrate for solution for infusion

Active Ingredient:
zoledronic acid
Company:  
Fresenius Kabi Ltd See contact details
ATC code: 
M05BA08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Patient Reminder Card Zoledronic acid 4 mg/5 ml concentrate for solution for infusion

This reminder card contains important safety information that you need to be aware of before and during treatment with zoledronic acid (4 mg/5 ml concentrate for solution for infusion) injections for cancer-related conditions.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Fresenius Kabi Ltd
Company image
Address
Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT
Telephone
+44 (0)1928 533 533
Fax
+44 (0)1928 533 420
Medical Information Direct Line
+44 (0)1928 533 575
Medical Information e-mail
[email protected]
Stock Availability
[email protected]
Customer Care direct line
+44 (0)1928 533 533
Medical Information Fax
+44 (0)1928 533 587
WWW
https://www.fresenius-kabi.com/gb/